Insider · CIK 0001370348
Craig A Johnson
director
Files at HRTX (HERON THERAPEUTICS, INC. /DE/), AUPH (Aurinia Pharmaceuticals Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | AUPH Aurinia Pharmaceuticals Inc. | FTax withholding Common Shares | -6,039 | $15.68 | $95k | 14,592 | Nov 24, 2025 |
| May 16, 2025 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Director Stock Option (right to buy)derivative | +37,485 | $0.00 | $0 | 37,485 | May 16, 2025 |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Common Stock | +17,950 | $0.00 | $0 | 83,770 | Feb 3, 2025 |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Stock Option (Right to Buy)derivative | +35,900 | $1.73 | $62k | 35,900 | Feb 3, 2025 |
| Nov 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Common Shares | +20,631 | $0.00 | $0 | 20,631 | Nov 25, 2024 |
| Nov 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Director Stock Option (right to buy)derivative | +31,688 | $0.00 | $0 | 31,688 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.